Tags

Type your tag names separated by a space and hit enter

The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.
Psychopharmacology (Berl) 1984; 84(2):217-20P

Abstract

Dopaminergic behavioral supersensitivity may be induced by chronic treatment with either dopaminergic agonists or antagonists. We demonstrate that the development of agonist-induced supersensitivity is resistant to chronic lithium exposure. Furthermore, chronic lithium alone enhances the stereotypic response to acute dopamine agonist administration and this effect of lithium summates with the behavioral augmentation caused by chronic amphetamine exposure. Although marked dopamine-related behavioral changes occur, chronic treatment with amphetamine, lithium, or both had no effect on levels of DA, DOPAC, HVA, and 3MT in either the striatum or nucleus accumbens. These results suggest that chronic amphetamine treatment with or without lithium does not affect presynaptic dopamine metabolism as assessed by metabolite levels. Furthermore, amphetamine-induced behavioral supersensitivity is not a simple function of changes in dopamine metabolism.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

6438680

Citation

Rubin, E H., and G F. Wooten. "The Behavioral and Biochemical Effects of Lithium On Dopaminergic Agonist-induced Supersensitivity." Psychopharmacology, vol. 84, no. 2, 1984, pp. 217-20.
Rubin EH, Wooten GF. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. Psychopharmacology (Berl). 1984;84(2):217-20.
Rubin, E. H., & Wooten, G. F. (1984). The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. Psychopharmacology, 84(2), pp. 217-20.
Rubin EH, Wooten GF. The Behavioral and Biochemical Effects of Lithium On Dopaminergic Agonist-induced Supersensitivity. Psychopharmacology (Berl). 1984;84(2):217-20. PubMed PMID: 6438680.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. AU - Rubin,E H, AU - Wooten,G F, PY - 1984/1/1/pubmed PY - 1984/1/1/medline PY - 1984/1/1/entrez SP - 217 EP - 20 JF - Psychopharmacology JO - Psychopharmacology (Berl.) VL - 84 IS - 2 N2 - Dopaminergic behavioral supersensitivity may be induced by chronic treatment with either dopaminergic agonists or antagonists. We demonstrate that the development of agonist-induced supersensitivity is resistant to chronic lithium exposure. Furthermore, chronic lithium alone enhances the stereotypic response to acute dopamine agonist administration and this effect of lithium summates with the behavioral augmentation caused by chronic amphetamine exposure. Although marked dopamine-related behavioral changes occur, chronic treatment with amphetamine, lithium, or both had no effect on levels of DA, DOPAC, HVA, and 3MT in either the striatum or nucleus accumbens. These results suggest that chronic amphetamine treatment with or without lithium does not affect presynaptic dopamine metabolism as assessed by metabolite levels. Furthermore, amphetamine-induced behavioral supersensitivity is not a simple function of changes in dopamine metabolism. SN - 0033-3158 UR - https://www.unboundmedicine.com/medline/citation/6438680/The_behavioral_and_biochemical_effects_of_lithium_on_dopaminergic_agonist_induced_supersensitivity_ DB - PRIME DP - Unbound Medicine ER -